PubMed:9376579
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 35-100 | DNA | denotes | novel human myeloid-selective CCAAT/enhancer binding protein gene |
| T2 | 102-115 | DNA | denotes | C/EBP epsilon |
| T3 | 124-137 | DNA | denotes | C/EBP epsilon |
| T4 | 174-204 | protein | denotes | CCAAT/enhancer binding protein |
| T5 | 306-324 | RNA | denotes | C/EBP epsilon mRNA |
| T6 | 352-361 | cell_line | denotes | NB4 cells |
| T7 | 363-390 | cell_line | denotes | promyelocytic leukemia line |
| T8 | 478-490 | cell_type | denotes | granulocytes |
| T9 | 508-526 | RNA | denotes | C/EBP epsilon mRNA |
| T10 | 573-582 | cell_line | denotes | NB4 cells |
| T11 | 771-789 | RNA | denotes | C/EBP epsilon mRNA |
| T12 | 862-871 | cell_line | denotes | NB4 cells |
| T13 | 1076-1094 | RNA | denotes | C/EBP epsilon mRNA |
| T14 | 1298-1301 | cell_line | denotes | NB4 |
| T15 | 1320-1338 | RNA | denotes | C/EBP epsilon mRNA |
| T16 | 1413-1431 | RNA | denotes | C/EBP epsilon mRNA |
| T17 | 1497-1515 | RNA | denotes | C/EBP epsilon mRNA |
| T18 | 1562-1577 | protein | denotes | protein factors |
| T19 | 1603-1621 | RNA | denotes | C/EBP epsilon mRNA |
| T20 | 1708-1729 | protein | denotes | C/EBP epsilon protein |
| T21 | 1733-1742 | cell_line | denotes | NB4 cells |
| T22 | 1906-1917 | cell_line | denotes | HL-60 cells |
| T23 | 1992-2010 | RNA | denotes | C/EBP epsilon mRNA |
| T24 | 2069-2087 | RNA | denotes | C/EBP epsilon mRNA |
| T25 | 2116-2133 | cell_line | denotes | NB4 promyelocytes |
| T26 | 2184-2196 | cell_type | denotes | granulocytes |
| T27 | 2216-2234 | RNA | denotes | C/EBP epsilon mRNA |
| T28 | 2329-2344 | protein | denotes | protein factors |
| T29 | 2366-2397 | DNA | denotes | C/EBP epsilon promoter/enhancer |
| T30 | 2409-2439 | DNA | denotes | retinoic acid-response element |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-117 | Sentence | denotes | Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). |
| S2 | 118-271 | Sentence | denotes | Human C/EBP epsilon is a newly cloned gene coding for a CCAAT/enhancer binding protein that may be involved in the regulation of myeloid differentiation. |
| S3 | 272-491 | Sentence | denotes | Our studies showed that levels of C/EBP epsilon mRNA were markedly increased in NB4 cells (promyelocytic leukemia line), because they were induced by 9-cis retinoic acid (9-cis RA) to differentiate towards granulocytes. |
| S4 | 492-666 | Sentence | denotes | Accumulation of C/EBP epsilon mRNA occurred as early as 1 hour after exposure of NB4 cells to 9-cis RA (5 x 10(-7) mol/L); and at 48 hours, levels were increased by 5.1-fold. |
| S5 | 667-861 | Sentence | denotes | Dose-response studies showed that 10(-7) to 10(-6) mol/L 9-cis RA (12 hours) resulted in peak levels of C/EBP epsilon mRNA; but even 10(-10) mol/L 9-cis RA increased levels of these transcripts. |
| S6 | 862-1267 | Sentence | denotes | NB4 cells pulse-exposed (30 minutes) to all-trans retinoic acid (ATRA), washed, and cultured (3 days) with either dimethylsulfoxide (DMSO) or hexamethylene bisacetamide (HMBA) had a prominent increase in levels of C/EBP epsilon mRNA and an increase in granulocytic differentiation, but exposure to either DMSO or HMBA alone had no effect on base levels of C/EBP epsilon and did not induce differentiation. |
| S7 | 1268-1339 | Sentence | denotes | Macrophage-differentiation of NB4 reduced levels of C/EBP epsilon mRNA. |
| S8 | 1340-1478 | Sentence | denotes | Nuclear run-off assays and half-life studies showed that accumulation of C/EBP epsilon mRNA by 9-cis RA was due to enhanced transcription. |
| S9 | 1479-1675 | Sentence | denotes | Furthermore, this C/EBP epsilon mRNA accumulation did not require synthesis of new protein factors because 9-cis RA induced C/EBP epsilon mRNA accumulation in the absence of new protein synthesis. |
| S10 | 1676-1773 | Sentence | denotes | ATRA also induced expression of C/EBP epsilon protein in NB4 cells, as shown by Western blotting. |
| S11 | 1774-2018 | Sentence | denotes | In contrast to the increase of C/EBP epsilon in 9-cis RA-mediated granulocytic differentiation, the DMSO-induced differentiation of HL-60 cells down the granulocytic pathway was associated with an initial reduction of C/EBP epsilon mRNA levels. |
| S12 | 2019-2197 | Sentence | denotes | In summary, we have discovered that expression of C/EBP epsilon mRNA is markedly enhanced as the NB4 promyelocytes are induced by retinoids to differentiate towards granulocytes. |
| S13 | 2198-2345 | Sentence | denotes | This induction of C/EBP epsilon mRNA expression is transcriptionally mediated and occurs in the absence of synthesis of additional protein factors. |
| S14 | 2346-2481 | Sentence | denotes | We suspect that the C/EBP epsilon promoter/enhancer contains a retinoic acid-response element that is directly stimulated by retinoids. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 33-116 | NP | denotes | a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon) |
| C1 | 14-116 | NP | denotes | mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon) |
| C3 | 118-137 | NP | denotes | Human C/EBP epsilon |
| C4 | 172-204 | NP | denotes | a CCAAT/enhancer binding protein |
| C5 | 205-209 | NP | denotes | that |
| C7 | 306-324 | NP | denotes | C/EBP epsilon mRNA |
| C6 | 296-324 | NP | denotes | levels of C/EBP epsilon mRNA |
| C8 | 352-391 | NP | denotes | NB4 cells (promyelocytic leukemia line) |
| C9 | 401-405 | NP | denotes | they |
| C10 | 422-452 | NP | denotes | 9-cis retinoic acid (9-cis RA) |
| C11 | 478-490 | NP | denotes | granulocytes |
| C13 | 508-526 | NP | denotes | C/EBP epsilon mRNA |
| C12 | 492-526 | NP | denotes | Accumulation of C/EBP epsilon mRNA |
| C14 | 573-582 | NP | denotes | NB4 cells |
| C15 | 771-790 | NP | denotes | C/EBP epsilon mRNA; |
| C17 | 843-860 | NP | denotes | these transcripts |
| C16 | 833-860 | NP | denotes | levels of these transcripts |
| C18 | 902-932 | NP | denotes | all-trans retinoic acid (ATRA) |
| C19 | 976-1000 | NP | denotes | dimethylsulfoxide (DMSO) |
| C20 | 1004-1037 | NP | denotes | hexamethylene bisacetamide (HMBA) |
| C22 | 1076-1094 | NP | denotes | C/EBP epsilon mRNA |
| C21 | 1066-1094 | NP | denotes | levels of C/EBP epsilon mRNA |
| C23 | 1167-1171 | NP | denotes | DMSO |
| C24 | 1175-1179 | NP | denotes | HMBA |
| C25 | 1218-1231 | NP | denotes | C/EBP epsilon |
| C26 | 1320-1338 | NP | denotes | C/EBP epsilon mRNA |
| C28 | 1413-1431 | NP | denotes | C/EBP epsilon mRNA |
| C29 | 1435-1443 | NP | denotes | 9-cis RA |
| C27 | 1397-1443 | NP | denotes | accumulation of C/EBP epsilon mRNA by 9-cis RA |
| C30 | 1492-1528 | NP | denotes | this C/EBP epsilon mRNA accumulation |
| C31 | 1586-1594 | NP | denotes | 9-cis RA |
| C32 | 1603-1634 | NP | denotes | C/EBP epsilon mRNA accumulation |
| C33 | 1676-1680 | NP | denotes | ATRA |
| C34 | 1733-1742 | NP | denotes | NB4 cells |
| C35 | 1992-2017 | NP | denotes | C/EBP epsilon mRNA levels |
| C37 | 2069-2087 | NP | denotes | C/EBP epsilon mRNA |
| C36 | 2055-2087 | NP | denotes | expression of C/EBP epsilon mRNA |
| C38 | 2149-2158 | NP | denotes | retinoids |
| C39 | 2184-2196 | NP | denotes | granulocytes |
| C40 | 2216-2245 | NP | denotes | C/EBP epsilon mRNA expression |
| C41 | 2407-2439 | NP | denotes | a retinoic acid-response element |
| C42 | 2440-2444 | NP | denotes | that |
| C43 | 2471-2480 | NP | denotes | retinoids |
| R1 | C3 | C2 | coref-ident | Human C/EBP epsilon,a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon) |
| R2 | C5 | C4 | coref-relat | that,a CCAAT/enhancer binding protein |
| R3 | C9 | C7 | coref-pron | they,C/EBP epsilon mRNA |
| R4 | C13 | C7 | coref-ident | C/EBP epsilon mRNA,C/EBP epsilon mRNA |
| R5 | C14 | C8 | coref-ident | NB4 cells,NB4 cells (promyelocytic leukemia line) |
| R6 | C15 | C13 | coref-ident | C/EBP epsilon mRNA;,C/EBP epsilon mRNA |
| R7 | C17 | C15 | coref-ident | these transcripts,C/EBP epsilon mRNA; |
| R8 | C16 | C6 | coref-ident | levels of these transcripts,levels of C/EBP epsilon mRNA |
| R9 | C22 | C15 | coref-ident | C/EBP epsilon mRNA,C/EBP epsilon mRNA; |
| R10 | C21 | C16 | coref-ident | levels of C/EBP epsilon mRNA,levels of these transcripts |
| R11 | C23 | C19 | coref-ident | DMSO,dimethylsulfoxide (DMSO) |
| R12 | C24 | C20 | coref-ident | HMBA,hexamethylene bisacetamide (HMBA) |
| R13 | C25 | C3 | coref-ident | C/EBP epsilon,Human C/EBP epsilon |
| R14 | C26 | C22 | coref-ident | C/EBP epsilon mRNA,C/EBP epsilon mRNA |
| R15 | C28 | C26 | coref-ident | C/EBP epsilon mRNA,C/EBP epsilon mRNA |
| R16 | C29 | C10 | coref-ident | 9-cis RA,9-cis retinoic acid (9-cis RA) |
| R17 | C27 | C12 | coref-ident | accumulation of C/EBP epsilon mRNA by 9-cis RA,Accumulation of C/EBP epsilon mRNA |
| R18 | C30 | C27 | coref-ident | this C/EBP epsilon mRNA accumulation,accumulation of C/EBP epsilon mRNA by 9-cis RA |
| R19 | C31 | C29 | coref-ident | 9-cis RA,9-cis RA |
| R20 | C32 | C30 | coref-ident | C/EBP epsilon mRNA accumulation,this C/EBP epsilon mRNA accumulation |
| R21 | C33 | C18 | coref-ident | ATRA,all-trans retinoic acid (ATRA) |
| R22 | C34 | C14 | coref-ident | NB4 cells,NB4 cells |
| R23 | C35 | C21 | coref-ident | C/EBP epsilon mRNA levels,levels of C/EBP epsilon mRNA |
| R24 | C37 | C28 | coref-ident | C/EBP epsilon mRNA,C/EBP epsilon mRNA |
| R25 | C36 | C1 | coref-ident | expression of C/EBP epsilon mRNA,mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon) |
| R26 | C39 | C11 | coref-ident | granulocytes,granulocytes |
| R27 | C40 | C36 | coref-ident | C/EBP epsilon mRNA expression,expression of C/EBP epsilon mRNA |
| R28 | C42 | C41 | coref-relat | that,a retinoic acid-response element |
| R29 | C43 | C38 | coref-ident | retinoids,retinoids |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-29 | other_name | denotes | mRNA expression |
| T2 | 35-100 | DNA_domain_or_region | denotes | novel human myeloid-selective CCAAT/enhancer binding protein gene |
| T3 | 102-115 | DNA_domain_or_region | denotes | C/EBP epsilon |
| T4 | 124-137 | DNA_domain_or_region | denotes | C/EBP epsilon |
| T5 | 174-204 | protein_family_or_group | denotes | CCAAT/enhancer binding protein |
| T6 | 247-270 | other_name | denotes | myeloid differentiation |
| T7 | 306-324 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T8 | 352-361 | cell_line | denotes | NB4 cells |
| T9 | 363-390 | cell_line | denotes | promyelocytic leukemia line |
| T10 | 422-441 | other_organic_compound | denotes | 9-cis retinoic acid |
| T11 | 443-451 | other_organic_compound | denotes | 9-cis RA |
| T12 | 478-490 | cell_type | denotes | granulocytes |
| T13 | 508-526 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T14 | 573-582 | cell_line | denotes | NB4 cells |
| T15 | 586-594 | other_organic_compound | denotes | 9-cis RA |
| T16 | 724-732 | other_organic_compound | denotes | 9-cis RA |
| T17 | 771-789 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T18 | 814-822 | other_organic_compound | denotes | 9-cis RA |
| T19 | 862-871 | cell_line | denotes | NB4 cells |
| T20 | 902-925 | other_organic_compound | denotes | all-trans retinoic acid |
| T21 | 927-931 | other_organic_compound | denotes | ATRA |
| T22 | 976-993 | other_organic_compound | denotes | dimethylsulfoxide |
| T23 | 995-999 | other_organic_compound | denotes | DMSO |
| T24 | 1004-1030 | other_organic_compound | denotes | hexamethylene bisacetamide |
| T25 | 1032-1036 | other_organic_compound | denotes | HMBA |
| T26 | 1076-1094 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T27 | 1114-1142 | other_name | denotes | granulocytic differentiation |
| T28 | 1167-1171 | other_organic_compound | denotes | DMSO |
| T29 | 1175-1179 | other_organic_compound | denotes | HMBA |
| T30 | 1268-1294 | other_name | denotes | Macrophage-differentiation |
| T31 | 1298-1301 | cell_line | denotes | NB4 |
| T32 | 1320-1338 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T33 | 1340-1362 | other_name | denotes | Nuclear run-off assays |
| T34 | 1367-1384 | other_name | denotes | half-life studies |
| T35 | 1413-1431 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T36 | 1435-1443 | other_organic_compound | denotes | 9-cis RA |
| T37 | 1497-1515 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T38 | 1562-1577 | protein_family_or_group | denotes | protein factors |
| T39 | 1586-1594 | other_organic_compound | denotes | 9-cis RA |
| T40 | 1603-1621 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T41 | 1657-1674 | other_name | denotes | protein synthesis |
| T42 | 1676-1680 | other_organic_compound | denotes | ATRA |
| T43 | 1708-1729 | protein_molecule | denotes | C/EBP epsilon protein |
| T44 | 1733-1742 | cell_line | denotes | NB4 cells |
| T45 | 1756-1772 | other_name | denotes | Western blotting |
| T46 | 1822-1830 | other_organic_compound | denotes | 9-cis RA |
| T47 | 1840-1868 | other_name | denotes | granulocytic differentiation |
| T48 | 1874-1878 | other_organic_compound | denotes | DMSO |
| T49 | 1906-1917 | cell_line | denotes | HL-60 cells |
| T50 | 1927-1947 | other_name | denotes | granulocytic pathway |
| T51 | 1992-2010 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T52 | 2069-2087 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T53 | 2116-2133 | cell_line | denotes | NB4 promyelocytes |
| T54 | 2184-2196 | cell_type | denotes | granulocytes |
| T55 | 2216-2234 | RNA_molecule | denotes | C/EBP epsilon mRNA |
| T56 | 2329-2344 | protein_family_or_group | denotes | protein factors |
| T57 | 2366-2397 | DNA_domain_or_region | denotes | C/EBP epsilon promoter/enhancer |
| T58 | 2409-2439 | DNA_domain_or_region | denotes | retinoic acid-response element |
| T59 | 2471-2480 | other_organic_compound | denotes | retinoids |